Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:59 pm Purchase | 2024-02-13 | 13G | Cinemark Holdings, Inc. CNK | Barclays PLC | 7,695,410 6.320% | 7,695,410 (New Position) | Filing History |
| 2024-02-14 4:52 pm Purchase | 2024-02-13 | 13G | DUET Acquisition Corp. DUET | Barclays PLC | 354,200 6.420% | 354,200 (New Position) | Filing History |
| 2024-02-14 4:49 pm Purchase | 2024-02-13 | 13G | NanoString Technologies, Inc. NSTGQ | Barclays PLC | 3,411,407 7.090% | 3,411,407 (New Position) | Filing History |
| 2024-02-14 4:37 pm Sale | 2024-02-13 | 13G | EON Resources Inc. EONR | Barclays PLC | 425,000 8.340% | -304,200 (-41.72%) | Filing History |
| 2024-02-08 8:32 pm Sale | 2023-12-31 | 13G | Barclays PLC BCS | Qatar Investment Authority | 420,120,691 2.800% | -379,999,999 (-47.49%) | Filing History |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | Barclays PLC BCS | BlackRock Inc. BLK | 1,303,920,163 8.600% | -79,809,943 (-5.77%) | Filing |
| 2023-02-10 3:09 pm Purchase | 2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Weiss Asset Management LP | 7,457,060 11.090% | 7,457,060 (New Position) | Filing History |
| 2023-02-07 2:10 pm Sale | 2022-12-31 | 13G | Barclays PLC BCS | BlackRock Inc. BLK | 1,383,730,106 8.700% | -18,022,585 (-1.29%) | Filing |
| 2023-01-30 3:43 pm Purchase | 2023-01-10 | 13G | InterPrivate III Financial Partners Inc. IPVF | Barclays PLC | 1,711,085 6.390% | 1,711,085 (New Position) | Filing History |
| 2023-01-30 3:06 pm Purchase | 2023-01-11 | 13G | Theravance Biopharma, Inc. TBPH | Barclays PLC | 3,402,767 5.050% | 3,402,767 (New Position) | Filing History |
| 2023-01-30 3:04 pm Purchase | 2023-01-10 | 13G | VALUENCE MERGER CORP I VMCAF | Barclays PLC | 1,170,865 5.320% | 1,170,865 (New Position) | Filing History |
| 2023-01-30 2:49 pm Purchase | 2023-01-10 | 13G | Integrated Rail and Resources Acquisition Corp. IRRX | Barclays PLC | 1,478,876 6.430% | 1,478,876 (New Position) | Filing History |
| 2023-01-30 12:50 pm Purchase | 2023-01-10 | 13G | SHUAA Partners Acquisition Corp I SHUA | Barclays PLC | 646,132 5.950% | 646,132 (New Position) | Filing History |
| 2023-01-30 12:48 pm Purchase | 2023-01-10 | 13G | OPAL Fuels Inc. OPAL | Barclays PLC | 2,042,561 7.960% | 2,042,561 (New Position) | Filing History |
| 2023-01-30 12:13 pm Purchase | 2023-01-10 | 13G | TZP Strategies Acquisition Corp. TZPS | Barclays PLC | 1,609,399 5.600% | 1,609,399 (New Position) | Filing History |
| 2023-01-30 12:11 pm Purchase | 2023-01-10 | 13G | Build Acquisition Corp. BGSX | Barclays PLC | 1,003,350 5.020% | 1,003,350 (New Position) | Filing History |
| 2023-01-30 12:11 pm Purchase | 2023-01-10 | 13G | World Quantum Growth Acquisition Corp. WQGA | Barclays PLC | 1,485,707 7.290% | 1,485,707 (New Position) | Filing History |
| 2023-01-30 12:10 pm Purchase | 2023-01-10 | 13G | Levere Holdings Corp. LVRA | Barclays PLC | 1,469,415 5.420% | 1,469,415 (New Position) | Filing History |
| 2023-01-30 12:05 pm Purchase | 2023-01-10 | 13G | Newbury Street Acquisition Corporation NBST | Barclays PLC | 841,565 7.600% | 841,565 (New Position) | Filing History |
| 2023-01-30 12:04 pm Purchase | 2023-01-10 | 13G | Seaport Global Acquisition II Corp. SGII | Barclays PLC | 1,095,131 7.620% | 1,095,131 (New Position) | Filing History |